Home
Edge Pharma

Edge Pharma Market Share Analysis for February 2026

Health > Pharmacy

Domainedgepharma.com

Year Founded1989

Employees51 - 200

Annual Revenue$15M - $25M

Edge Pharma

Edge Pharma (including company regionals)

edgepharma.com

See more website traffic and engagement information

Edge Pharma Revenue up to February 2026 is 15M - 25M

revenue generated by Edge Pharma top domains

Edge Pharma top domains revenue over 3 years

Revenue for Edge Pharma top domains

edgepharma.com15M - 25M

See more with Sales Intelligence

Total visits to Edge Pharma's top domains

Understand Edge Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

edgepharma.com22.6K

See more with Sales Intelligence

Avg. visit duration in Edge Pharma's top domains

Analyze Edge Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

edgepharma.com00:10:04

See more with Sales Intelligence

Avg. pageviews on Edge Pharma's top domains

See how Edge Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

edgepharma.com11.27

See more with Sales Intelligence

Edge Pharma top competitors by domain

Top similar sites in February 2026, ranked by their affinity

genomedx.comCompany NameGenomeDx BiosciencesEmployees51 - 200HQCanada, VancouverAnnual revenue--Total visits4.5KHealth > Health Conditions and Concerns

Top technologies used by Edge Pharma

These are the website technologies, by industry, used by Edge Pharma top domains

Advertising (8)

DoubleClick

Content Management System (3)

WordPress

Email Services (3)

Sendgrid

Widget (3)

reCAPTCHA

More Technologies

7

See all

News & Signals from Edge Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAzurity Pharmaceuticals, Inc. files suit against Edgepharma.This case raises important issues, including: Azurity filed its complaint against Edge Pharma in federal court in Massachusetts, alleging that Edge’s practice of manufacturing and selling an oral vancomycin hydrochloride solution that is identical or nearly identical to Azurity’s FIRVANQ constitutes unfair competition and false advertising in violation of the Lanham Act and unfair and deceptive trade practices in violation of Massachusetts General Law Chapter 93A.